Notice Number: NOT-AI-09-001

Key Dates
Release Date: October 17, 2008
Receipt Date: February 10, 2009

Issued by
National Institutes of Allergy and Infectious Diseases (NIAID), (http://www.niaid.nih.gov)

Description

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases.  The NIAID, Division of Allergy, Immunology, and Transplantation (DAIT) has a requirement for a Reagent Resource which will develop, obtain, evaluate, produce, and distribute a wide variety of reagents to facilitate and advance NHP research in infectious and immune-mediated diseases. The Contractor shall operate and manage the NHP Reagent Resource to develop, obtain, evaluate, produce, and distribute a wide variety of reagents to facilitate and advance NHP research in infectious and immune-mediated diseases.

Examples of reagent categories include monoclonal antibodies (mAbs), receptor/ligands, chimeric/recombinant proteins or mAbs, transformed cell lines, transforming virus stocks, and other novel state-of-the-art reagents required for in vivo or in vitro 1) evaluation or monitoring of immune responses; 2) depletion of select immune cells; and 3) modulation or alteration of immune responses. The development of new reagents and the modification of existing reagents for use in NHP research will be supported.

The NHP species that are the primary focus of this RFP are the 1) Cynomolgus macaque (Macaca fasicularis); 2) Rhesus macaque (Macaca mulatta); 3) Pigtail macaque (Macaca nemestrina); and 4) Baboon (Papio hamadryas). Reagent development for additional species of non-human primates may be required to meet the needs of the Government or the research community.

Under unusual circumstance, a reagent may be provided for limited use for other than NHP research, e.g. by an investigator who has provided a given mAb cell line to the Contractor and requires material for his/her own non-NHP research use.

Costs for reagent production are recovered from investigators only for large quantities of reagents, typically gram quantities used for in vivo experiments. All other costs are covered under the contract.
Initial distribution capacity shall be for approximately 300 shipments per year, with potential to increase to 400 shipments per year.

The major scope of functions to be performed by the contractor are: Identification, Prioritization and Approval of Candidate Reagents, Reagent Development Proposals, Reagent Development, Reagent Production, Purification, and Quality Control, Distribution, Tracking and Inventory, NHP Reagent Resource Website and Communications with the NHP Research Community

It is anticipated that one cost reimbursement completion type contract will be awarded for a five-year period of performance beginning on or about September 1, 2009. Government Options may extend the contract for up to an additional two (2) years to continue services required during base period.   It is estimated that the provision of FTEs will be approximately 5.1 FTE’s.

Any responsible office may submit a proposal which will be considered by the Agency.  This RFP will be available electronically on/about October 10, 2008 and may be accessed through FedBizOpps http://www.fedbizopps.gov/.  This notice does not commit the Government to award a contract.  No collect calls will be accepted.  No facsimile transmissions will be accepted. All information required for submission of an offer will be contained in the RFP. Responses to this RFP will be due on February 10, 2009.

Inquiries

For questions or further information, contact:

Tom Bahrami,
Contract Specialist
Office of Acquisitions, Division of Extramural Activities, NIAID, NIH, DHHS
6700-B Rockledge Drive Room 3214, MSC 7612 (Express mail:  Use Zip Code 20817-7612)
Phone: 301-451-2654
Fax: 301-451-5430
bahramit@niaid.nih.gov

David T. Lisle,
Contracting Officer
Office of Acquisitions, Division of Extramural Activities, NIAID, NIH, DHHS
6700-B Rockledge Drive Room 3214, MSC 7612 (Express mail:  Use Zip Code 20817-7612)
Phone: 301-451-2617
Fax: 301-402-0972
dlisle@niaid.nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.